Morris VK, Ciombor KK, Xiao L, Ochieng JK, et al. NCI9673 (Part B): ETCTN Randomized Phase II Study of Nivolumab With or Without Ipilimumab in Refractory, Metastatic Squamous Cell Carcinoma of the Anal Canal. J Clin Oncol 2026;44:497-507.
PMID: 41499716